In this time of dire need, Sepragen team is doing its part to solve the problem of COVID-19. We are providing equipment on an expedited basis to a company developing a vaccine for COVID- 19.
Continuous Chromatography System

Continuous Chromatography System

The Fusion QuantaSep® consists of 2-column or 3-column continuous capture and automated flow through skid with all Chromatographic steps and Nanofiltration process integrated into single straight-through skids

Date
September 2022
share
news
You may also like
Browse All
January 2023
Sepragen ships
In the creation of bio-pharmaceutical drugs, cells are genetically modified to produce some compound shown by research to have a desired effect in a treatment program.
Learn more
December 2022
Sepragen completes installation
Sepragen’s products or tools are used to manufacture over 24 FDA approved drugs including Kogenate®, Alphanate®, Neupogen®, and GammaGrand®* along with a multitude...
Learn more
July 2022
Sepragen presents at the Recovery Conference in Rome
Sepragen has pioneered the three patented processes for the isolation of high value nutritionals on a commercial scale. The Sepralac® Process enables the isolation of Lactoferrin...
Learn more
Sepragen, the original inventors of radial flow chromatography, is dedicated to supplying powerful, innovative tools and technologies which enable our customers to develop and manufacture life-saving biological drugs, vaccines and diagnostics quickly and cost-effectively.

©2026 - Sepragen Corporation - All right reserved

Contacts